Rezolute (RZLT) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.53% |
| Dec 31, 2025 | 12.68% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | -93.17% |
| Mar 31, 2025 | 9.95% |
| Dec 31, 2024 | 10.87% |
| Sep 30, 2024 | 14.66% |
| Jun 30, 2024 | -58.61% |
| Mar 31, 2024 | 13.62% |
| Dec 31, 2023 | 6.27% |
| Sep 30, 2023 | 3.04% |
| Jun 30, 2023 | 1.13% |
| Mar 31, 2023 | 29.77% |
| Dec 31, 2022 | 4.91% |
| Sep 30, 2022 | -2.60% |
| Jun 30, 2022 | -137.18% |
| Mar 31, 2022 | 18.07% |
| Dec 31, 2021 | -107.51% |
| Sep 30, 2021 | 9.13% |
| Jun 30, 2021 | -28.32% |
| Mar 31, 2021 | 14.92% |
| Dec 31, 2020 | -487.13% |
| Sep 30, 2020 | 91.73% |
| Jun 30, 2020 | -451.58% |
| Mar 31, 2020 | 22.82% |
| Dec 31, 2019 | 17.74% |
| Sep 30, 2019 | 41.21% |
| Jun 30, 2019 | -145.05% |
| Mar 31, 2019 | -5,847.29% |
| Dec 31, 2018 | 35.66% |
| Sep 30, 2018 | 75.64% |
| Mar 31, 2012 | 56.18% |
| Dec 31, 2011 | 32.51% |
| Sep 30, 2011 | 36.60% |
| Jun 30, 2011 | 8.69% |
| Mar 31, 2011 | -0.01% |
| Dec 31, 2010 | -1,251.63% |